Monopar Therapeutics Inc. MNPR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

48/100

2/6 Pass

SharesGrow Intrinsic Value

Monopar Therapeutics Inc. (MNPR) has 19 known insider and institutional holders on record. The largest holder is TacticGem LLC with 7,166,667 shares. Other notable holders include Gem Pharmaceuticals LLC and Hendricks Diane.

Over the last 12 months, insiders have made 28 transactions in MNPR stock — 13 buys (valued at $6.45M) and 2 sells (valued at $35.03M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

MNPR Insider Ownership

Top Holder

TacticGem LLC

7,166,667 shares

Buys (12 mo)

$6.45M value

Sells (12 mo)

$35.03M value

12-Month Transaction Activity

Buy 46%

Sell 7%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Tacticgem Llc	Officer	7,166,667	2018-01-08	100%
2	Gem Pharmaceuticals Llc	Officer	3,055,394	2018-01-08	43%
3	Hendricks Diane	10 Percent Owner	567,580	2025-12-17	8%
4	Tactic Pharma Llc	10 Percent Owner	272,026	2025-09-26	4%
5	Filho Jose Octavio Pinto Costa	Officer	91,500	2021-07-13	1%
6	Robinson Chandler	Chief Executive Officer	90,478	2026-04-02	1%
7	Rodriguez Susan	Ccso	48,728	2026-03-04	1%
8	Cittadine Andrew	Chief Operating Officer	44,753	2026-04-02	1%
9	Mazar Andrew Paul	Chief Scientific Officer	22,125	2022-04-01	0%
10	Klausner Arthur J	Director	8,762	2025-12-19	0%
11	Tsuchimoto Kim R	Director	2,924	2025-12-08	0%
12	Talukdar Lavina	Director	2,924	2025-12-08	0%
13	Anderson Raymond	Director	2,924	2025-12-08	0%
14	Starr Christopher M	Director	2,924	2025-12-08	0%
15	Brown Michael J	Director	2,533	2023-10-03	0%
16	Rioux Patrice	Other: Acting Chief Medical Officer	2,000	2026-01-05	0%
17	Radhakrishnan Karthik	Chief Financial Officer	1,550	2024-10-30	0%
18	Vu Quan Anh	Chief Financial Officer	1,500	2025-12-29	0%
19	Leo Karl	Officer	314	2019-12-20	0%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-31	Cittadine Andrew	Chief Operating Officer	Option Exercise (Sell)	3,514	-	-
2026-03-31	Robinson Chandler	Chief Executive Officer	Tax Withholding of RSU	1,972	$54.79	$108.05K
2026-03-02	Rodriguez Susan	Ccso	RSU Award	48,728	$53.47	$2.61M
2026-03-02	Rodriguez Susan	Officer	Unknown	-	-	-
2025-01-28	Robinson Chandler	Chief Executive Officer	Other (Buy)	62,815	-	-
2025-12-31	Cittadine Andrew	Chief Operating Officer	Option Exercise (Sell)	4,326	-	-
2025-12-31	Robinson Chandler	Chief Executive Officer	Tax Withholding of RSU	2,558	$65.30	$167.04K
2026-01-01	Rioux Patrice	Other: Acting Chief Medical Officer	RSU Award	2,000	$65.30	$130.6K
2025-12-26	Vu Quan Anh	Chief Financial Officer	Informative Buy	1,500	$69.95	$104.93K
2025-12-18	Klausner Arthur J	Director	Informative Sell	461	$68.09	$31.39K
2025-12-16	Hendricks Diane	10 Percent Owner	Other (Sell)	43,499	-	-
2025-12-16	Klausner Arthur J	Director	Other (Buy)	7,710	-	-
2025-12-02	Talukdar Lavina	Director	RSU Award	2,924	$75.94	$222.05K
2025-12-02	Vu Quan Anh	Chief Financial Officer	RSU Award	7,135	$75.94	$541.83K
2025-12-02	Cittadine Andrew	Chief Operating Officer	RSU Award	8,969	$75.94	$681.11K
2025-12-02	Robinson Chandler	Chief Executive Officer	RSU Award	16,753	$75.94	$1.27M
2025-12-02	Anderson Raymond	Director	RSU Award	2,924	$75.94	$222.05K
2025-12-02	Tsuchimoto Kim R	Director	RSU Award	2,924	$75.94	$222.05K
2025-12-02	Starr Christopher M	Director	RSU Award	2,924	$75.94	$222.05K
2025-12-02	Klausner Arthur J	Director	RSU Award	2,924	$75.94	$222.05K
2025-09-30	Cittadine Andrew	Chief Operating Officer	Option Exercise (Sell)	4,327	-	-
2025-09-30	Robinson Chandler	Chief Executive Officer	Option Exercise (Sell)	8,726	-	-
2025-09-24	Tactic Pharma Llc	10 Percent Owner	Informative Sell	550,229	$63.61	$35M
2025-07-14	Robinson Chandler	Chief Executive Officer	Option Exercise (ITM)	16,800	$0.01	$84.00
2025-07-14	Tsuchimoto Kim R	Director	Option Exercise (ITM)	4,704	$0.01	$23.52